UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Which Budgeting Approach Works Best contrasts common methods and offers a practical way to determine the most effective budgeting strategy for you.
25,562 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Imagine Micron topping a trillion-dollar market cap. The market would react in unpredictable ways. This guide explain...
Rocket Lab stands as the only public space stock with a direct line to actual launches and defense demand, even as Sp...
At Fortune Brainstorm Tech in Aspen, Twitch CEO Dan Clancy argued that live streaming builds real human connection th...
Investors are abuzz over SpaceX’s potential IPO, yet a new danger lurks: leveraged ETFs designed to double daily move...
The headline figure shows a $1,235 weekly paycheck before deductions, but take-home pay sits closer to $850 after tax...
Many portfolios miss a steady, high-quality income source. This article explains why the bond most investors overlook...
The yen is on a renewed slide, with policymakers juggling debt, inflation, and global rate moves as quietly crashing ...
Microsoft’s latest earnings show a resilient AI-powered expansion, with a $627 billion backlog and a near $37 billion...
Three ETFs are positioning investors for the next leg of AI-driven growth, offering diversified exposure as markets r...
Walmart’s stock falls after a softer-than-expected quarterly report, as U.S. store sales grow slowly and the profit o...
Meta Platforms is stepping up its AI push, pledging $115B-$135B in AI CapEx while moving to closed-source models. Inv...